Navigation Links
FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing
Date:11/14/2007

NUTLEY, N.J., Nov. 14 /PRNewswire-USNewswire/ -- Roche announced today that the U.S. Food and Drug Administration (FDA) has approved MIRCERA (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia associated with chronic renal failure (CRF) in adults, including patients on dialysis and patients not on dialysis. CRF is commonly known as chronic kidney disease (CKD). MIRCERA is the only FDA-approved erythropoiesis-stimulating agent (ESA) to provide correction of anemia with once-every-two-week dosing. MIRCERA is also the only FDA-approved ESA to maintain stable hemoglobin levels with once-monthly or once-every-two-week dosing in CKD patients. MIRCERA offers the added convenience of storage at room temperature for extended time periods when necessary.

The outcome of an ongoing patent case will determine when patients can gain access to MIRCERA in the United States. Following approval by the European Agency for the Evaluation of Medicinal Products (EMEA), MIRCERA has already been launched in Austria, Sweden, Germany, the United Kingdom and Norway, and will continue its international rollout.

"Roche is pleased that the approved FDA label reflects the differentiating characteristics of MIRCERA," said George B. Abercrombie, President and Chief Executive Officer, Hoffmann-La Roche Inc. "In Europe, thousands of patients with chronic renal failure and their physicians are receiving effective, predictable and convenient anemia treatment with MIRCERA, and we are hopeful that patients and healthcare providers in the U.S. will be able to have access to MIRCERA as soon as possible, in a responsible and legal manner."

In contrast to erythropoietin, MIRCERA is an erythropoietin receptor activator with greater activity in vivo as well as increased half-life. MIRCERA has the longest half-life of all FDA-approved ESAs, up to six times longer than darbepoetin alfa and up to 20 times longer than epoetin.

The initial registration clinical
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... December 25, 2014 Plugin creators from ... 5k. A fully customizable business presentation tool made specifically ... the ProFire 5k business tool, users can now display ... CEO of Pixel Film Studios. “ProFire 5k gives users ... to add professionalism to a presentation” , Pixel Film ...
(Date:12/24/2014)... Wauwatosa, Wi (PRWEB) December 25, 2014 ... who are unable to afford certain items. During the holiday ... , "We collected over 70 toys," says Dr. Sara Mahalko-Leonhardt, ... myself and staff such joy, knowing that we are able ... any present had it not been for the generosity of ...
(Date:12/24/2014)... Recently, iFitDress.com, a famous dress manufacturer and ... under $150 . All these items are brand new; they ... already been updated with the new range of high quality ... far. All iFitDress.com’s designs are made according to the latest ... materials. Every outfit from the company is handpicked by skilled ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 ... ) that allege the blood thinner caused life-threatening ... outlined a leadership structure for the proceeding, Bernstein ... December 17th, the Court plans to select lawyers ... and also plans on appointing a Plaintiffs’ Steering ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... promises, claimed patients in a survey despite the government promises ... patients survey has found high levels of general satisfaction with ... of the 80,000 people who took part a different picture ... ‘very clean’ as compared to 56% in 2002. While at ...
... the NHS staff should be praised for their efforts and ... the "best ever". He said that the maximum waiting time ... ,Reports indicated that the figures up to 31st ... with an 18-week wait for treatment was at its lowest ...
... in Ranchi, the Jharkhand Health department today said the ... // ,'We have equipped the Sadar hospital ... patients,' Health and Family Welfare's joint secretary R C ... free treatment at the hospital instead of streaming to ...
... world , including India, must face the challenges of ... their citizens get access to effective healthcare // , ... medical expenses, a new World Bank report said. ... to cope with sharply rising costs even while countries ...
... of the anti-quota strike call given by the Indian ... (BMC) // and Government Dental colleges today struck ... services in Victoria and Vani Vilas and government dental ... affected, Dr Venugopal, President, Junior Doctors Assoication, BMC told ...
... 25 (pti) As part of Tsunami relief efforts ... inaugurated at Thennampattinam, a tsunami-hit village in Sirkali ... Wucherer,member, corporate executive committee of Siemens, AG declared ... community and Consulate General, Earthquake assistant foundation through ...
Cached Medicine News:Health News:Quality Of NHS Hospitals Getting Dirtier Despite Promises 2Health News:Health Minister Praises Efforts By NHS In Reducing Patient Waiting Time 2Health News:Health Minister Praises Efforts By NHS In Reducing Patient Waiting Time 3
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
(Date:12/24/2014)... , December 24, 2014 ... at an average rate of 8.1%. The US has ... knee and spine surgeries are the common orthopedic procedures ... have a lower penetration. Increased number of product recalls ... Non-metallic orthopedic devices have gained popularity in the industry ...
(Date:12/24/2014)... , December 24, 2014 ... Report on Global Disposable Syringe Industry of ... its online business intelligence library. ... Disposable Syringe Industry is a professional and ... market.  For overview analysis, the report introduces ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... a new study, Cymbalta,(duloxetine HCl) 60-120 mg, taken ... in patients with osteoarthritis pain of,the knee. Data ... presented at the annual meeting of the American ... Duloxetine-treated patients showed greater ...
... Jan. 29 Scientists at NanoBio Corp. and,the ... that their,novel topical nanoemulsion kills the highly resistant strains ... with cystic fibrosis. , The ... for,treating resistant bacteria that lead to pulmonary failure in ...
Cached Medicine Technology:Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study 2Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study 3Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study 4Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study 5Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis 2Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis 3
7 mm strong curved blade. Round handle....
3 mm diameter roller blade in line with handle. Curved shaft. Flat handle. 15 mm from curve to tip....
5 mm diameter blade. Angled 45 degrees. Hexagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
Medicine Products: